Atypical haemolytic uraemic syndrome: a case of rare genetic mutation

被引:1
作者
Sangeetha, Geminiganesan [1 ]
Jayaraj, Jaippreetha [2 ]
Ganesan, Swathi [2 ]
Puttagunta, Sreeapoorva [3 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Dept Paediat Nephrol, Chennai, Tamil Nadu, India
[2] Sri Ramachandra Inst Higher Educ & Res, Chennai, Tamil Nadu, India
[3] Sri Ramachandra Inst Higher Educ & Res, Dept Paediat, Chennai, Tamil Nadu, India
关键词
genetics; haematology (incl blood transfusion); immunology; paediatrics; renal medicine; ECULIZUMAB; MANAGEMENT; CONSENSUS;
D O I
10.1136/bcr-2021-244190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Complement-mediated kidney disease has been an evolving area in the field of nephrology. Atypical haemolytic uraemic syndrome (aHUS) is a rare thrombotic microangiopathy that affects multiple organs, particularly kidneys. The disease is characterised by a triad of haemolytic anaemia, thrombocytopenia and acute kidney injury (AKI). aHUS is most commonly caused by dysregulation of alternative complement pathway. In contrast to shiga toxin-associated haemolytic uraemic syndrome, diarrheal prodrome is usually absent in children with aHUS. We report a 2-year, 9-month-old boy who presented with acute dysentery and AKI. He had an unusual prolonged course of illness with hypocomplementaemia; hence, genetic testing was performed. He had a storming course in the hospital and succumbed to complications of the disease. Genetic study revealed digenic mutation in Complement Factor I and C3. Therefore, it is important to differentiate aHUS from other thrombotic microangiopathies to improve the outcome.
引用
收藏
页数:4
相关论文
共 19 条
[1]   Atypical hemolytic uremic syndrome [J].
Afshar-Kharghan, Vahid .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, :217-225
[2]  
[Anonymous], Atypical hemolytic uremic syndrome
[3]   The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment [J].
Ariceta, Gema ;
Dixon, Bradley P. ;
Kim, Seong Heon ;
Kapur, Gaurav ;
Mauch, Teri ;
Ortiz, Stephan ;
Vallee, Marc ;
Denker, Andrew E. ;
Kang, Hee Gyung ;
Greenbaum, Larry A. .
KIDNEY INTERNATIONAL, 2021, 100 (01) :225-237
[4]   Hemolytic uremic syndrome in a developing country: Consensus guidelines [J].
Bagga, Arvind ;
Khandelwal, Priyanka ;
Mishra, Kirtisudha ;
Thergaonkar, Ranjeet ;
Vasudevan, Anil ;
Sharma, Jyoti ;
Patnaik, Saroj Kumar ;
Sinha, Aditi ;
Sethi, Sidharth ;
Hari, Pankaj ;
Dragon-Durey, Marie-Agnes ;
Mishra, Kirtisudha ;
Banerjee, Sushmita ;
Afzal, Kamran ;
Krishnamurthy, Sriram ;
Bhatt, Girish ;
Kumar, Manish ;
Puraswani, Mamta ;
Vasudevan, Anil ;
Sharma, Jyoti ;
Agarwal, Indira ;
Mishra, O. P. ;
Tiewsoh, Karalanglin ;
Sinha, Aditi ;
Patnaik, Saroj K. ;
Mehta, Amarjeet ;
Uthup, Susan ;
Sinha, Rajiv ;
Ekambaram, Sudha ;
Hari, Pankaj ;
Sethi, Sidharth ;
Saha, Abhijeet ;
Bhardwaj, Swati ;
Khandelwal, Priyanka ;
Bagga, Arvind .
PEDIATRIC NEPHROLOGY, 2019, 34 (08) :1465-1482
[5]   Hemolytic Uremic Syndrome: New Developments in Pathogenesis and Treatment [J].
Boyer, Olivia ;
Niaudet, Patrick .
INTERNATIONAL JOURNAL OF NEPHROLOGY, 2011, 2011
[6]   Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation [J].
Cayci, F. Semsa ;
Cakar, Nilgun ;
Hancer, Veysel Sabri ;
Uncu, Nermin ;
Acar, Banu ;
Gur, Gokce .
PEDIATRIC NEPHROLOGY, 2012, 27 (12) :2327-2331
[7]   Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome [J].
Greenbaum, Larry A. ;
Fila, Marc ;
Ardissino, Gianluigi ;
Al-Akash, Samhar I. ;
Evans, Jonathan ;
Henning, Paul ;
Lieberman, Kenneth V. ;
Maringhini, Silvio ;
Pape, Lars ;
Rees, Lesley ;
van de Kar, Nicole C. A. J. ;
Vande Walle, Johan ;
Ogawa, Masayo ;
Bedrosian, Camille L. ;
Licht, Christoph .
KIDNEY INTERNATIONAL, 2016, 89 (03) :701-711
[8]   Complement disorders and hemolytic uremic syndrome [J].
Joseph, Catherine ;
Gattineni, Jyothsna .
CURRENT OPINION IN PEDIATRICS, 2013, 25 (02) :209-215
[9]   Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome [J].
Kavanagh, David ;
Richards, Anna ;
Fremeaux-Bacchi, Veronique ;
Noris, Marina ;
Goodship, Timothy ;
Remuzzi, Giuseppe ;
Atkinson, John P. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (03) :591-596
[10]   Guidelines on Hemolytic Uremic Syndrome by Indian Society of Pediatric Nephrology: Key Messages [J].
Khandelwal, Priyanka ;
Bagga, Arvind .
INDIAN PEDIATRICS, 2020, 57 (08) :744-747